In tauopathies, including AD, metal dyshomeostasis, dysregulated cellular metabolism and oxidative stress stimulate the post-translational modification of tau, which alters the hydrophobicity, folding and stability of the protein, thus triggering its aggregation. The gene discussed is MAPT; the disease is Alzheimer disease.